Literature DB >> 2866971

Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at mu- and kappa-opioid receptor sites in rabbit and guinea-pig cerebellum membranes.

B Frances, C Moisand, J C Meunier.   

Abstract

Rabbit and guinea-pig cerebellum membrane preparations contain a high proportion (greater than 80%) of mu- and of kappa-opioid binding sites, respectively. These preparations were therefore used to compare the regulation of binding of mu- and of kappa-opioid agonists and antagonists by sodium ions and by guanyl-5'-yl imidodiphosphate. We report here that Na+ ions, Gpp(NH)p and most efficiently, the two agents in association selectively inhibited binding of opioid agonists not only in the mu preparation (rabbit cerebellum) but also in the kappa preparation (guinea-pig cerebellum). These allosteric effectors did not inhibit equilibrium binding of antagonists (naloxone, Mr 2266 or diprenorphine) in the two preparations. Taken together these results suggest that occupancy either of the mu-receptor by a mu-agonist or of the kappa-receptor by a kappa-agonist may be accompanied by similar if not identical molecular events. They also suggest a method to rapidly screen newly designed drugs as mu- or kappa-opioid agonists or antagonists.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866971     DOI: 10.1016/0014-2999(85)90607-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  N,N-diallyl-tyrosyl substitution confers antagonist properties on the kappa-selective opioid peptide [D-Pro10]dynorphin A(1-11).

Authors:  J E Gairin; H Mazarguil; P Alvinerie; C Botanch; J Cros; J C Meunier
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

2.  Control by cations of opioid binding in guinea pig brain membranes.

Authors:  S J Paterson; L E Robson; H W Kosterlitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  ICI 204448: a kappa-opioid agonist with limited access to the CNS.

Authors:  J S Shaw; J A Carroll; P Alcock; B G Main
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

4.  G protein signaling-biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists.

Authors:  Edward L Stahl; Cullen L Schmid; Agnes Acevedo-Canabal; Cai Read; Travis W Grim; Nicole M Kennedy; Thomas D Bannister; Laura M Bohn
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-30       Impact factor: 12.779

5.  Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes.

Authors:  A Richardson; C Demoliou-Mason; E A Barnard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

6.  mu opiate receptor: cDNA cloning and expression.

Authors:  J B Wang; Y Imai; C M Eppler; P Gregor; C E Spivak; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats.

Authors:  P L Tao; C R Lee; P Y Law; H H Loh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

8.  Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2.

Authors:  Adam J Kuszak; Sethuramasundaram Pitchiaya; Jessica P Anand; Henry I Mosberg; Nils G Walter; Roger K Sunahara
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.